Accuracy of the interferon-γ release assay for the diagnosis of active tuberculosis among HIV-seropositive individuals: a systematic review and meta-analysis
Open Access
- 22 July 2016
- journal article
- research article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 16 (1) , 1-11
Abstract
Although the interferon-γ release assay (IGRA) has become a widely accepted means for the diagnosis of latent tuberculosis infection (LTBI), the role of the IGRA in diagnosing active tuberculosis (ATB) among human immunodeficiency virus (HIV)-seropositive individuals remains controversial. Previous analyses did not set up rational inclusive criteria for screening articles with strict control groups and a gold standard for ATB diagnosis. Therefore, we conducted a systematic review of the latest evidence to evaluate the accuracy of IGRA for HIV-seropositive patients. Initially, we searched the EMBASE, Cochrane and MEDLINE databases to find research articles published from January 2000 to October 2015 that used the QuantiFERON-TB Gold In-Tube assay (QFT-IT) or the T-SPOT.TB assay (T-SPOT) to diagnose ATB among HIV-seropositive individuals. We separately calculated the pooled sensitivity, specificity, and proportion of indeterminate events and then summarized the results using forest plots to estimate the accuracy of the QFT-IT and T-SPOT assays. A total of 1,743 studies were discovered after searching; 11 studies met our selection standards and were included for meta-analysis. The pooled sensitivity and specificity of the QFT-IT assay were 69 % (95 % CI, 50–84 %, I2 = 85.22 %) and 76 % (95 % CI, 53–90 %, I2 = 98.16 %), respectively, and the optimum area under the curve (AUC) was 0.78 (95 % CI, 0.74–0.82). The pooled sensitivity and specificity of the T-SPOT assay were 89 % (95 % CI, 66–97 %, I2 = 94.48 %) and 87 % (95 % CI, 38–99 %, I2 = 97.92 %), respectively, and the AUC was 0.93 (95 % CI, 0.90–0.95). The pooled ratios of the indeterminate results of the QFT-IT and T-SPOT assays were 0.07 (95 % CI, 0.06–0.09, I2 = 74.8 %) and 0.19 (95 % CI, 0.15–0.24, I2 = 88.3 %), respectively, calculated using the fixed effect model, and 0.08 (95 % CI, 0.06–0.12, I2 = 74.8 %) and 0.10 (95 % CI, 0.03–0.25, I2 = 88.3 %), respectively, calculated using the random effects model. The IGRA does not appear to be optimal for the clinical confirmation of ATB cases in HIV-seropositive patients; however, the T-SPOT assay may have greater accuracy in distinguishing ATB cases among HIV-infected individuals than the QFT-IT assay, while the QFT-IT assay appears to reduce the occurrence of indeterminate results. Furthermore, modification and additional trial designs are required to improve diagnostic effectiveness.Keywords
Funding Information
- the National Key Clinical Specialist Construction Programs of China [2012] (NO. 649)
This publication has 28 references indexed in Scilit:
- A Toolbox for Tuberculosis (TB) Diagnosis: An Indian Multicentric Study (2006–2008). Evaluation of QuantiFERON-TB Gold in Tube for TB DiagnosisPLOS ONE, 2013
- Interferon-γ Release Assays for the Diagnosis of Tuberculosis and Tuberculosis Infection in HIV-Infected Adults: A Systematic Review and Meta-AnalysisPLOS ONE, 2012
- Interferon-γ Release Assays for Active Pulmonary Tuberculosis Diagnosis in Adults in Low- and Middle-Income Countries: Systematic Review and Meta-analysisThe Journal of Infectious Diseases, 2011
- Interferon-Gamma Release Assays for the Diagnosis of Active Tuberculosis in HIV-Infected Patients: A Systematic Review and Meta-AnalysisPLOS ONE, 2011
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy StudiesAnnals of Internal Medicine, 2011
- Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithmsEuropean Respiratory Journal, 2011
- Interferon-γ release assay in people infected with immunodeficiency virusClinical Microbiology and Infection, 2011
- Performance of QuantiFERON-TB Gold In-Tube (QFTGIT) for the diagnosis of Mycobacterium tuberculosis (Mtb) infection in Afar Pastoralists, EthiopiaBMC Infectious Diseases, 2010
- Role of interferon-gamma release assays in the diagnosis of pulmonary tuberculosis in patients with advanced HIV infectionBMC Infectious Diseases, 2010
- QuantiFERON-TB GOLD ELISA assay for the detection ofMycobacterium tuberculosis-specific antigens in blood specimens of HIV-positive patients in a high-burden countryFEMS Immunology & Medical Microbiology, 2009